$22.15
0.231.05%
Pre-Market: 6:55 AM EDT
Comments
Loading...
Latest news for Teva Pharmaceutical Indus (NYSE:TEVA) Stock
Teva Pharmaceutical Indus Stock (NYSE: TEVA)
Categories: All
Friday, January 17, 2025
- Teva Challenges Drug Price Law's Impact On Innovation, Generics
- Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
- Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
- 'Ozempic Is In The Next Round Of Medicare Dru...
- Piper Sandler Maintains Overweight on Teva Ph...
Monday, January 13, 2025
Friday, January 10, 2025
Thursday, January 09, 2025
Wednesday, January 08, 2025
Monday, January 06, 2025
Wednesday, December 25, 2024
Tuesday, December 24, 2024
Sunday, December 22, 2024
Wednesday, December 18, 2024
Tuesday, December 17, 2024
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday
- Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
- Teva shares are trading higher after the comp...
- Teva And Sanofi Announce Primary Endpoints Me...
Monday, December 16, 2024
Friday, December 13, 2024
Wednesday, December 11, 2024
Thursday, December 05, 2024
Wednesday, December 04, 2024
Friday, November 29, 2024
Saturday, November 16, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
- Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
- Teva Pharmaceutical CEO Francis Says Expects ...
- Teva shares are trading higher after the comp...
- Teva Forecasts 2024 Revenues Of $16.1B-$16.5B...
- Teva Forecasts 2024 Adjusted EPS Of $2.40-$2....
- Teva Pharmaceutical Indus Q3 2024 Adj EPS $0....